Literature DB >> 23811942

Acquired expression of NFATc1 downregulates E-cadherin and promotes cancer cell invasion.

Tsukasa Oikawa1, Atsuko Nakamura, Nobuyuki Onishi, Taketo Yamada, Koichi Matsuo, Hideyuki Saya.   

Abstract

NFATc1 is a transcription factor that regulates T-cell development, osteoclastogenesis, and macrophage function. Given that T cells, osteoclasts, and macrophages in the tumor microenvironment are thought to modulate tumor progression, tumor cells may acquire NFATc1 expression through fusion with these NFATc1-expressing normal cells. We here revealed that a small proportion of tumor cells in human carcinoma specimens expressed NFATc1. To investigate the consequences of NFATc1 acquisition by tumor cells, we established A549 and MCF7 cell lines expressing a constitutively active form of NFATc1 (NFATc1CA) in an inducible manner. The expression of NFATc1CA promoted cancer cell invasion in association with changes in cell morphology. Analysis of gene expression and RNA interference experiments revealed that NFATc1CA suppressed E-cadherin expression by upregulating the transcriptional repressors Snail and Zeb1 in a manner independent of TGF-β signaling. Induced expression of NFATc1CA also downregulated E-cadherin expression and increased invasive activity in tumor xenografts in vivo. Our results thus suggest that the acquisition of NFATc1 expression contributes to tumor progression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23811942     DOI: 10.1158/0008-5472.CAN-13-0274

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  NFAT1 promotes intratumoral neutrophil infiltration by regulating IL8 expression in breast cancer.

Authors:  Aura Kaunisto; Whitney S Henry; Laleh Montaser-Kouhsari; Shou-Ching Jaminet; Eun-Yeong Oh; Li Zhao; Hongbo R Luo; Andrew H Beck; Alex Toker
Journal:  Mol Oncol       Date:  2015-02-19       Impact factor: 6.603

2.  Nuclear factor of activated T-cell activity is associated with metastatic capacity in colon cancer.

Authors:  Manish K Tripathi; Natasha G Deane; Jing Zhu; Hanbing An; Shinji Mima; Xiaojing Wang; Sekhar Padmanabhan; Zhiao Shi; Naresh Prodduturi; Kristen K Ciombor; Xi Chen; M Kay Washington; Bing Zhang; R Daniel Beauchamp
Journal:  Cancer Res       Date:  2014-10-15       Impact factor: 12.701

3.  Salt-inducible kinase 3 protects tumor cells from cytotoxic T-cell attack by promoting TNF-induced NF-κB activation.

Authors:  Antonio Sorrentino; Ayse Nur Menevse; Tillmann Michels; Valentina Volpin; Franziska Christine Durst; Julian Sax; Maria Xydia; Abir Hussein; Slava Stamova; Steffen Spoerl; Nicole Heuschneider; Jasmin Muehlbauer; Katharina Marlene Jeltsch; Anchana Rathinasamy; Melanie Werner-Klein; Marco Breinig; Damian Mikietyn; Christian Kohler; Isabel Poschke; Sabrina Purr; Olivia Reidell; Catarina Martins Freire; Rienk Offringa; Claudia Gebhard; Rainer Spang; Michael Rehli; Michael Boutros; Christian Schmidl; Nisit Khandelwal; Philipp Beckhove
Journal:  J Immunother Cancer       Date:  2022-05       Impact factor: 12.469

4.  NFATC1 promotes cell growth and tumorigenesis in ovarian cancer up-regulating c-Myc through ERK1/2/p38 MAPK signal pathway.

Authors:  Wenwen Xu; Junjie Gu; Qingling Ren; Yanqiu Shi; Qinhua Xia; Jing Wang; Suli Wang; Yingchun Wang; Jinhua Wang
Journal:  Tumour Biol       Date:  2015-10-26

5.  Interleukin (IL)-7 Signaling in the Tumor Microenvironment.

Authors:  Iwona Bednarz-Misa; Mariusz A Bromke; Małgorzata Krzystek-Korpacka
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  The T-box transcription factor, TBX3, is a key substrate of AKT3 in melanomagenesis.

Authors:  Jade Peres; Shaheen Mowla; Sharon Prince
Journal:  Oncotarget       Date:  2015-01-30

7.  Inhibiting NFAT1 for breast cancer therapy: New insights into the mechanism of action of MDM2 inhibitor JapA.

Authors:  Jiang-Jiang Qin; Wei Wang; Sukesh Voruganti; Hui Wang; Wei-Dong Zhang; Ruiwen Zhang
Journal:  Oncotarget       Date:  2015-10-20

8.  Loss of endogenous Nfatc1 reduces the rate of DMBA/TPA-induced skin tumorigenesis.

Authors:  Jill Goldstein; Eve Roth; Natalie Roberts; Rachel Zwick; Samantha Lin; Sean Fletcher; Ana Tadeu; Christine Wu; Amanda Beck; Caroline Zeiss; Mayte Suárez-Fariñas; Valerie Horsley
Journal:  Mol Biol Cell       Date:  2015-08-26       Impact factor: 4.138

9.  Identification of potential regulatory mutations using multi-omics analysis and haplotyping of lung adenocarcinoma cell lines.

Authors:  Sarun Sereewattanawoot; Ayako Suzuki; Masahide Seki; Yoshitaka Sakamoto; Takashi Kohno; Sumio Sugano; Katsuya Tsuchihara; Yutaka Suzuki
Journal:  Sci Rep       Date:  2018-03-21       Impact factor: 4.379

10.  FBXL20 acts as an invasion inducer and mediates E-cadherin in colorectal adenocarcinoma.

Authors:  Jianjun Zhu; Shishan Deng; Jie Duan; Xingguo Xie; Shiquan Xu; Maocheng Ran; Xiaosi Dai; Yu Pu; Xiaoming Zhang
Journal:  Oncol Lett       Date:  2014-04-03       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.